3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Uterine Cervical Neoplasms
1
Sarcoma
1
Pseudomyxoma Peritonei
1
Prostatic Neoplasms
1
Papillomavirus Infections
1
Ovarian Neoplasms
1
Mesothelioma, Malignant
1
Lymphoma
1
Lung Neoplasms
1
Kidney Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Breast Neoplasms
1
Appendiceal Neoplasms
1
Interventions
pembrolizumab
8
Oxaliplatin
7
Surveys and Questionnaires
5
Methods
5
Early Intervention, Educational
5
Cyclophosphamide
5
Cisplatin
5
Paclitaxel
4
Magnetic Resonance Spectroscopy
4
Leucovorin
4
Gemcitabine
4
Fluorouracil
4
Carboplatin
4
veliparib
3
aldesleukin
3
Trastuzumab
3
Specimen Handling
3
Nivolumab
3
Diathermy
3
Cytoreduction Surgical Procedures
3
sargramostim
2
entinostat
2
cemiplimab
2
cediranib
2
X-Rays
2
Therapeutics
2
Radiotherapy
2
Psychiatric Rehabilitation
2
Polymerase Chain Reaction
2
Metformin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Colonic Neoplasms
×
Referral and Consultation
×
Gynecologic
×
Clear all
NCT01126346
2018-07-03
HOPE
Wake Forest University Health Sciences
Phase NA
Completed
10 enrolled